Literature DB >> 22968404

Alterations in mitochondrial function in cardiac hypertrophy and heart failure.

Moritz Osterholt1, T Dung Nguyen, Michael Schwarzer, Torsten Doenst.   

Abstract

Normal cardiac function requires high and continuous supply with ATP. As mitochondria are the major source of ATP production, it is apparent that mitochondrial function and cardiac function need to be closely related to each other. When subjected to overload, the heart hypertrophies. Initially, the development of hypertrophy is a compensatory mechanism, and contractile function is maintained. However, when the heart is excessively and/or persistently stressed, cardiac function may deteriorate, leading to the onset of heart failure. There is considerable evidence that alterations in mitochondrial function are involved in the decompensation of cardiac hypertrophy. Here, we review metabolic changes occurring at the mitochondrial level during the development of cardiac hypertrophy and the transition to heart failure. We will focus on changes in mitochondrial substrate metabolism, the electron transport chain and the role of oxidative stress. We will demonstrate that, with respect to mitochondrial adaptations, a clear distinction between hypertrophy and heart failure cannot be made because most of the findings present in overt heart failure can already be found in the various stages of hypertrophy.

Entities:  

Mesh:

Year:  2013        PMID: 22968404     DOI: 10.1007/s10741-012-9346-7

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  120 in total

Review 1.  Emerging roles of SIRT1 deacetylase in regulating cardiomyocyte survival and hypertrophy.

Authors:  Nagalingam R Sundaresan; Vinodkumar B Pillai; Mahesh P Gupta
Journal:  J Mol Cell Cardiol       Date:  2011-01-27       Impact factor: 5.000

2.  Hypertensive left ventricular hypertrophy is associated with abnormal myocardial fatty acid metabolism and myocardial efficiency.

Authors:  Lisa de las Fuentes; Pablo F Soto; Brian P Cupps; Michael K Pasque; Pilar Herrero; Robert J Gropler; Alan D Waggoner; Victor G Dávila-Román
Journal:  J Nucl Cardiol       Date:  2006 May-Jun       Impact factor: 5.952

3.  Specific and sustained down-regulation of genes involved in fatty acid metabolism is not a hallmark of progression to cardiac failure in mice.

Authors:  K F J de Brouwer; H Degens; W M Aartsen; M Lindhout; N J J E Bitsch; A J Gilde; P H M Willemsen; B J A Janssen; G J van der Vusse; M van Bilsen
Journal:  J Mol Cell Cardiol       Date:  2006-05-11       Impact factor: 5.000

Review 4.  Metabolic energetics and genetics in the heart.

Authors:  Heinrich Taegtmeyer; Christopher R Wilson; Peter Razeghi; Saumya Sharma
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

Review 5.  Mitochondrial protein phosphorylation as a regulatory modality: implications for mitochondrial dysfunction in heart failure.

Authors:  Brian O'Rourke; Jennifer E Van Eyk; D Brian Foster
Journal:  Congest Heart Fail       Date:  2011-11-09

6.  Hypertrophied rat hearts are less responsive to the metabolic and functional effects of insulin.

Authors:  M F Allard; R B Wambolt; S L Longnus; M Grist; C P Lydell; H L Parsons; B Rodrigues; J L Hall; W C Stanley; G P Bondy
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-09       Impact factor: 4.310

Review 7.  Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure.

Authors:  Julie R McMullen; Garry L Jennings
Journal:  Clin Exp Pharmacol Physiol       Date:  2007-04       Impact factor: 2.557

8.  Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy.

Authors:  S Neubauer; M Horn; M Cramer; K Harre; J B Newell; W Peters; T Pabst; G Ertl; D Hahn; J S Ingwall; K Kochsiek
Journal:  Circulation       Date:  1997-10-07       Impact factor: 29.690

9.  NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart.

Authors:  Junya Kuroda; Tetsuro Ago; Shouji Matsushima; Peiyong Zhai; Michael D Schneider; Junichi Sadoshima
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-16       Impact factor: 11.205

10.  Proteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure.

Authors:  Heiko Bugger; Michael Schwarzer; Dong Chen; Andrea Schrepper; Paulo A Amorim; Maria Schoepe; T Dung Nguyen; Friedrich W Mohr; Oleh Khalimonchuk; Bart C Weimer; Torsten Doenst
Journal:  Cardiovasc Res       Date:  2009-10-19       Impact factor: 10.787

View more
  19 in total

1.  Aerobic exercise training improves oxidative stress and ubiquitin proteasome system activity in heart of spontaneously hypertensive rats.

Authors:  Luiz Henrique Soares de Andrade; Wilson Max Almeida Monteiro de Moraes; Eduardo Hiroshi Matsuo Junior; Elizabeth de Orleans Carvalho de Moura; Hanna Karen Moreira Antunes; Jairo Montemor; Ednei Luiz Antonio; Danilo Sales Bocalini; Andrey Jorge Serra; Paulo José Ferreira Tucci; Patricia Chakur Brum; Alessandra Medeiros
Journal:  Mol Cell Biochem       Date:  2015-01-28       Impact factor: 3.396

2.  GLP-1 Improves Diastolic Function and Survival in Heart Failure with Preserved Ejection Fraction.

Authors:  T Dung Nguyen; Yasushige Shingu; Paulo A Amorim; Christina Schenkl; Michael Schwarzer; Torsten Doenst
Journal:  J Cardiovasc Transl Res       Date:  2018-02-20       Impact factor: 4.132

3.  Activation of TRPV1 attenuates high salt-induced cardiac hypertrophy through improvement of mitochondrial function.

Authors:  Hongmei Lang; Qiang Li; Hao Yu; Peng Li; Zongshi Lu; Shiqiang Xiong; Tao Yang; Yu Zhao; Xiaohu Huang; Peng Gao; Hexuan Zhang; Qianhui Shang; Daoyan Liu; Zhiming Zhu
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

4.  A New Minimally Invasive Method of Transverse Aortic Constriction in Mice.

Authors:  Huayang Li; Quan Liu; Shunjun Wang; Lin Huang; Suiqing Huang; Yuan Yue; Kangni Feng; Zhongkai Wu
Journal:  J Cardiovasc Transl Res       Date:  2021-09-08       Impact factor: 3.216

5.  Cardiomyocyte loss is not required for the progression of left ventricular hypertrophy induced by pressure overload in female mice.

Authors:  Julia Schipke; Clara Grimm; Georg Arnstein; Jens Kockskämper; Simon Sedej; Christian Mühlfeld
Journal:  J Anat       Date:  2016-03-17       Impact factor: 2.610

6.  Distinct Phenotypes Induced by Different Degrees of Transverse Aortic Constriction in C57BL/6N Mice.

Authors:  Haiyan Deng; Lei-Lei Ma; Fei-Juan Kong; Zengyong Qiao
Journal:  Front Cardiovasc Med       Date:  2021-04-22

7.  Global Transcriptomic Profiling of Cardiac Hypertrophy and Fatty Heart Induced by Long-Term High-Energy Diet in Bama Miniature Pigs.

Authors:  Jihan Xia; Yuanyuan Zhang; Leilei Xin; Siyuan Kong; Yaoxing Chen; Shulin Yang; Kui Li
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

Review 8.  Monoamine Oxidases as Potential Contributors to Oxidative Stress in Diabetes: Time for a Study in Patients Undergoing Heart Surgery.

Authors:  Oana M Duicu; Rodica Lighezan; Adrian Sturza; Raluca A Ceausu; Claudia Borza; Adrian Vaduva; Lavinia Noveanu; Marian Gaspar; Adina Ionac; Horea Feier; Danina M Muntean; Cristian Mornos
Journal:  Biomed Res Int       Date:  2015-05-25       Impact factor: 3.411

Review 9.  Pathogenesis of chronic cardiorenal syndrome: is there a role for oxidative stress?

Authors:  Speranza Rubattu; Silvia Mennuni; Marco Testa; Mara Mennuni; Giorgia Pierelli; Beniamino Pagliaro; Erica Gabriele; Roberta Coluccia; Camillo Autore; Massimo Volpe
Journal:  Int J Mol Sci       Date:  2013-11-20       Impact factor: 5.923

Review 10.  Pivotal Importance of STAT3 in Protecting the Heart from Acute and Chronic Stress: New Advancement and Unresolved Issues.

Authors:  Fouad A Zouein; Raffaele Altara; Qun Chen; Edward J Lesnefsky; Mazen Kurdi; George W Booz
Journal:  Front Cardiovasc Med       Date:  2015-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.